Emerson said net sales for fiscal 2024 were $17.5 billion, up 15% from the prior year, and underlying sales rose 6%. The Test & Measurement acquisition added 9.5%, while the divestiture of Metran deducted 0.5%.

1. 01

   Emerson said net sales for fiscal 2024 were $17.5 billion, up 15% from the prior year, and underlying sales rose 6%. The Test & Measurement acquisition added 9.5%, while the divestiture of Metran deducted 0.5%.

2. 02

   The company said diluted earnings per share from continuing operations for fiscal 2024 were $2.82, down 29% from $3.96 a year earlier. It cited purchase accounting impacts from the NI acquisition, higher restructuring costs and the loss on the sale of the Copeland note receivable as the reasons for the decline. Adjusted diluted EPS was $5.49, compared with $4.44 in the prior year.

3. 03

   Emerson said it agreed on June 6, 2024 to sell its 40% non-controlling equity interest in Copeland to $1.5 billion and its note receivable from Copeland to $1.9 billion, both to private equity funds managed by Blackstone, and completed the transactions in August. It recorded a pretax loss from continuing operations of $279 on the note, and a gain of $539 from the sale of the equity interest in discontinued operations.

4. 04

   The company said operating cash flow from continuing operations for fiscal 2024 was $3.3 billion, an increase of $607 (22%). Free cash flow was $2,898 (in millions), up 23%. Net cash paid for acquisitions was $8,342, dividends were $1,201 and share repurchases were $435 (each in millions).

Key figures

Fiscal year ended September 30, 2024

Revenue

$17.5B

Net income

$2.0B

EPS

$3.43

Gross profit

$8.9B

Operating cash flow

$3.3B

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.